The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 23, 2019

Filed:

May. 05, 2016
Applicant:

The Board of Trustees of the Leland Stanford Junior University, Stanford, CA (US);

Inventors:

Chia Chi Ho, Los Altos Hills, CA (US);

Kenan Christopher Garcia, Menlo Park, CA (US);

Aaron Michael Ring, New Haven, CT (US);

Kipp Andrew Weiskopf, Brookline, MA (US);

Irving L. Weissman, Stanford, CA (US);

Nan Guo Ring, New Haven, CT (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/705 (2006.01); C07K 16/30 (2006.01); A61K 38/17 (2006.01); A61K 39/395 (2006.01); G01N 33/50 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/70503 (2013.01); A61K 38/1774 (2013.01); A61K 39/39558 (2013.01); C07K 14/70596 (2013.01); C07K 16/30 (2013.01); G01N 33/5005 (2013.01); A61K 38/00 (2013.01); C07K 2319/21 (2013.01); C07K 2319/24 (2013.01); C07K 2319/30 (2013.01); C07K 2319/50 (2013.01);
Abstract

High affinity CD47 reagents are provided, which (i) comprise at least one amino acid change relative to the wild-type protein; and (ii) have an increased affinity for a SIRPα relative to the wild-type protein. Compositions and methods are provided for modulating phagocytosis in a mammal by administering a therapeutic dose of a pharmaceutical composition comprising a high affinity CD47 reagent, which blocks the physiological binding interaction between SIRPα and a ligand, e.g., native CD47.


Find Patent Forward Citations

Loading…